Technology | 2022.08.06
Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy
SHANGHAI, Aug. 6, 2022 /PRNewswire/ -- Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for wide variety of diseases, today announced it has secured $20 million in...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]editing-therapy-301601118.html
Follow us on
Instagram is adding automatic in-app text translation - The Verge views: 1569
Instagram is adding automatic in-app text translation - The Verge views: 1507